In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Vanda Pharmaceuticals Inc (NASDAQ: VNDA) was $5.13 for the day, up 1.58% from the previous closing price of $5.05. In other words, the price has increased by $1.58 from its previous closing price. On the day, 0.77 million shares were traded. VNDA stock price reached its highest trading level at $5.15 during the session, while it also had its lowest trading level at $5.035.
Ratios:
Our analysis of VNDA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.69 and its Current Ratio is at 4.71. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on February 25, 2022, Downgraded its rating to Hold and sets its target price to $12 from $24 previously.
On May 12, 2021, BofA Securities started tracking the stock assigning a Buy rating and target price of $22.
Citigroup Downgraded its Buy to Neutral on January 14, 2021, while the target price for the stock was maintained at $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’24 when Polymeropoulos Mihael Hristos sold 24,288 shares for $4.13 per share. The transaction valued at 100,273 led to the insider holds 1,871,730 shares of the business.
Wijkstrom Joakim sold 9,229 shares of VNDA for $38,830 on Mar 05 ’24. The SVP, Chief Marketing Officer now owns 129,789 shares after completing the transaction at $4.21 per share. On Mar 05 ’24, another insider, Moran Kevin Patrick, who serves as the SVP, CFO & Treasurer of the company, sold 8,902 shares for $4.20 each. As a result, the insider received 37,411 and left with 231,014 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNDA now has a Market Capitalization of 298557280 and an Enterprise Value of -86660856. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.68 while its Price-to-Book (P/B) ratio in mrq is 0.55. Its current Enterprise Value per Revenue stands at -0.488 whereas that against EBITDA is 4.201.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $6.76, while it has fallen to a 52-week low of $3.30. The 50-Day Moving Average of the stock is 16.72%, while the 200-Day Moving Average is calculated to be 16.65%.
Shares Statistics:
VNDA traded an average of 2.42M shares per day over the past three months and 1628480 shares per day over the past ten days. A total of 57.53M shares are outstanding, with a floating share count of 55.14M. Insiders hold about 5.26% of the company’s shares, while institutions hold 86.27% stake in the company. Shares short for VNDA as of 1714435200 were 2304708 with a Short Ratio of 0.95, compared to 1711584000 on 2485405. Therefore, it implies a Short% of Shares Outstanding of 2304708 and a Short% of Float of 4.79.
